Cantor Fitzgerald Has Positive View of AXSM FY2025 Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of Axsome Therapeutics in a research note issued to investors on Thursday, May 1st. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings of ($4.02) per share for the year, up […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of Axsome Therapeutics in a research note issued to investors on Thursday, May 1st. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings of ($4.02) per share for the year, up […]
